title: Enhanced negative inotropic effect of an adenosine A1-receptor agonist in rat left atria in hypothyroidism.
abstract: Left atria were isolated from rats made hypothyroid by adding propylthiouracil to their drinking water, such rats after saturating doses of thyroid hormones, and from control rats. Isoproterenol (ISO; 1 microM) increased the values of developed tension (DT), maximal rate of tension development (+dt/dt) and tension fall (-dT/dt). The effect was largest in hypothyroid and lowest in hyperthyroid atria. The adenosine A1-receptor agonist N6-(phenylisopropyl)-adenosine (PIA) had a powerful negative inotropic effect in ISO-stimulated atria. The effects of PIA on +dT/dt, -dT/dt and DT were enhanced in hypothyroidism. Adenosine receptor number was not decreased. The amount of total Gi-like proteins was estimated by pertussis toxin labeling. The amounts of Gi2 and Gi3 were estimated in Western blots using such antisera raised in rabbits against peptides corresponding to parts of their sequences, using purified recombinant alpha subunits as standards. The amounts of low and high molecular weight forms of Gs were estimated by cholera toxin labeling Gi2, Gi3 and pertussis toxin substrate concentrations were slightly lower in the hypothyroid animals, while the amounts of both forms of Gs per mg of protein were only half of those in euthyroid rat atria. The levels of Gi2 and Gi3 were greatly elevated as compared to Gs as membrane marker. These changes were reversed by treatment of the hypothyroid rats with thyroid hormones. In conclusion, the present results show an enhanced negative inotropic effect of an adenosine.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Pathophysiology, University of Tartu, Estonia.
authors.forename: A
authors.initials: A
authors.lastname: Kaasik
authors.forename: E K
authors.initials: EK
authors.lastname: Seppet
authors.forename: J J
authors.initials: JJ
authors.lastname: Ohisalo
mesh_terms: D000241:Adenosine / Q000494:pharmacology; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D016275:Atrial Function; D015153:Blotting, Western; D001835:Body Weight; D002395:Catecholamines / Q000494:pharmacology; D003864:Depression, Chemical; D005260:Female; D019204:GTP-Binding Proteins / Q000032:analysis / Q000378:metabolism / Q000502:physiology; D006325:Heart Atria / Q000737:chemistry / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006980:Hyperthyroidism / Q000378:metabolism / Q000503:physiopathology; D007037:Hypothyroidism / Q000378:metabolism / Q000503:physiopathology*; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology*; D010660:Phenylisopropyladenosine / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D018047:Receptors, Purinergic P1 / Q000032:analysis / Q000187:drug effects / Q000502:physiology
chemical_list: D000316:Adrenergic alpha-Agonists; D002395:Catecholamines; D018047:Receptors, Purinergic P1; D010660:Phenylisopropyladenosine; D019204:GTP-Binding Proteins; D000241:Adenosine; D007545:Isoproterenol